Aquestive Therapeutics Inc (AQST)

EBITDA

-$18.89M

Quarterly · Period ending: · USD

AQST logo

AQST EBITDA

Latest reported-$18.89M
AQST Quarterly EBITDA ($1.71M → -$18.89M)
High-resolution chart · PNG

AQST ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-18,888,000
-4,008,000
-27,457,000
-11,034,000
-9,132,000
-18,513,000
-12,698,000
-7,152,000
1,655,000
-8,421,000
-4,308,000
-600,000
-3,791,000
9,880,000
-10,251,000
-8,252,000
-12,063,000
-9,011,000
-24,625,000
-7,232,000
-5,402,000
-7,770,000
-14,364,000
-13,120,000
1,210,000
-12,872,000
-9,110,000
-15,016,000
-17,775,000
-12,017,000
-11,282,000
-12,359,000
-33,789,000
6,979,000
-7,103,000
11,409,000
-2,999,000
1,709,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.